0001213900-23-040577.txt : 20230516 0001213900-23-040577.hdr.sgml : 20230516 20230516175835 ACCESSION NUMBER: 0001213900-23-040577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230516 FILED AS OF DATE: 20230516 DATE AS OF CHANGE: 20230516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADAMS ERIC A CENTRAL INDEX KEY: 0001817882 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 23929036 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml X0407 4 2023-05-16 0 0001728328 InMed Pharmaceuticals Inc. INM 0001817882 ADAMS ERIC A C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 1 1 0 0 President & CEO 0 Employee Stock Option (Expiration) 623.93 2023-05-16 4 H 0 1818 0.00 D 2018-05-16 2023-05-16 Common shares 1818 26139 D Converted from the Canadian dollar exercise price of C$841.50 using an exchange rate of C$1.3487 = $US1.00 /s/ Eric A Adams 2023-05-16